Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe

被引：0
|
作者：
Taieb, J. [1 ]
Carrato, A. [2 ]
AMellbring [3 ]
Prager, G. [4 ]
Melisi, D. [5 ]
Westphalen, B. [6 ]
Macarulla Mercade, T. [7 ,8 ]
D'Esquermes, N. [9 ]
Ferreras, A. [10 ]
De Jong, F. [11 ]
机构：
[1] Paris Descartes Univ, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Paris, France
[2] Alcala Univ, Hosp Univ Ramon Y Cajal, CIBERONC, IRYCIS, Madrid, Spain
[3] Shire Sweden AB, Kista, Sweden
[4] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Clin Div Med Oncol, Vienna, Austria
[5] Univ Verona, Med Oncol, Verona, Italy
[6] Klinikum Univ Munchen, Comprehens Canc Ctr Munchen, Munich, Germany
[7] Vall dHebron Univ Hosp, Barcelona, Spain
[8] Vall dHebron Inst Oncol, Barcelona, Spain
[9] Genactis, Chateauneuf, France
[10] Genactis, Antibes, France
[11] Shire Int GmbH, Glattpark Opfikon, Switzerland
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 002
引用
收藏
页码：100 / +
页数：2
相关论文
共 50 条
  • [41] Outcomes in metastatic pancreatic adenocarcinoma (MPAC) patients treated with FOLFIRINOX (FFX)/FOLFOX(FX) and gemcitabine plus nab-paclitaxel (NabG).
    Schmidt, Shannon Leah
    Durkal, Vipal
    Jayavalsan, Shinoj Pattali
    Thomas, James P.
    Ritch, Paul S.
    Erickson, Beth
    Christians, Kathleen K.
    Tsai, Susan
    Evans, Douglas B.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] Third-line treatment options in metastatic pancreatic cancer patients: a real-world study
    Lu, Hong-Rui
    Zhu, Peng-Fei
    Deng, Ya-Ya
    Chen, Zhe-Ling
    Yang, Liu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [44] First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
    Taieb, Julien
    Prager, Gerald W.
    Melisi, Davide
    Westphalen, C. Benedikt
    D'Esquermes, Nathalie
    Ferreras, Anabel
    Carrato, Alfredo
    Macarulla, Teresa
    ESMO OPEN, 2020, 5 (01)
  • [45] Real-world overall survival of patients diagnosed with recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC).
    O'Reilly, Eileen Mary
    Yu, Kenneth H.
    Lamarre, Neil
    Surinach, Andy
    Cockrum, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Clinical outcomes of first-line chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma patients: Real-world experience
    Umpawan, N.
    Termsinsuk, P.
    Kaosombatwattana, U.
    Akewanlop, C.
    Korphaisarn, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S919 - S920
  • [47] Drug treatment in melanoma: A real-world analysis across Europe and Japan
    de Pinillos, A. Martinez
    Nasuti, P.
    Anger, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 459 - 459
  • [48] Real-world treatment patterns and total cost of care in Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Hirsch, Jared
    Cockrum, Paul
    Tomicki, Samantha
    Dieguez, Gabriela
    Bhatt, Prachi
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer Cohort
    Pijnappel, Esther N.
    Dijksterhuis, Willemieke P. M.
    van der Geest, Lydia G.
    de Vos-Geelen, Judith
    de Groot, Jan Willem B.
    Homs, Marjolein Y., V
    Creemers, Geert-jan
    Mohammad, Nadia Haj
    Besselink, Marc G.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05): : 443 - +
  • [50] Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review
    Cockrum, Paul
    Dennen, Syvart
    Brown, Audrey
    Briggs, Jonathon
    Paluri, Ravi
    FUTURE ONCOLOGY, 2025, 21 (02) : 241 - 260
12345